Your session is about to expire
← Back to Search
Procedure
Standard Ablation Technique for Supraventricular Tachycardia (AVNRT Trial)
N/A
Waitlist Available
Research Sponsored by Jeffrey Moak
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up during procedure- start to finish
Awards & highlights
No Placebo-Only Group
Summary
This trial compares two methods for correcting a heart condition called AVNRT. The first, called the New Ablation Technique, uses low voltage and wave front collision mapping. The second, called the Standard Ablation Technique, uses an anatomical/electrogram approach.
Eligible Conditions
- Supraventricular Tachycardia
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ during procedure- start to finish
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~during procedure- start to finish
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Primary end point - Number of lesions needed to achieve modification of slow AV nodal pathway
Secondary study objectives
Secondary End points - Time from start to end of ablation lesion application(s), and total length of procedure.
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Active Control
Group I: Standard Ablation TechniqueActive Control1 Intervention
Ablation performed using the traditional anatomical / electrogram guided ablation approach.
Group II: New Ablation TechniqueActive Control1 Intervention
Will undergo ablation using voltage mapping and triangle of Koch propagation wave collision mapping. Ablation will be performed at or slightly above the site of wave front collision.
Find a Location
Who is running the clinical trial?
Jeffrey MoakLead Sponsor
1 Previous Clinical Trials
870 Total Patients Enrolled
University of Wisconsin, MadisonOTHER
1,221 Previous Clinical Trials
3,167,184 Total Patients Enrolled
University of LouisvilleOTHER
344 Previous Clinical Trials
77,249 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger